Curriculum Vitae

DR. DIANA ONG BEE LAN

Medical Lecturer
  • Department of Pathology
    Faculty of Medicine

AREAS OF EXPERTISE

  • PATHOLOGY
    Anatomical Pathology

ACADEMIC QUALIFICATION

  • MPath, (Pathology)
    Universiti Malaya (UM)
  • MBBChBao, (Medicine and Surgery)
    University College Dublin

ADMINISTRATIVE DUTIES

  • Penasihat Kursus Diploma MLT
    01 Jan 2021 - 31 Dec 2023 (University Malaya)
  • Coordinator
    01 Dec 2021 - 31 Oct 2023 (National)
  • Academic Staff in-Charge of Medical Laboratory Technologist/ MLT- Diploma Coursse
    01 Sep 2013 - 28 Feb 2023 (Department of Pathology, Faculty of Medicine)
  • Secretary of Tabung Amanah Patologi PPUM
    01 Aug 2017 - 31 Jan 2023 (Department of Pathology, Faculty of Medicine)
  • Department of Pathology- librarian
    01 Sep 2013 - 31 Dec 2022 (Department of Pathology, Faculty of Medicine)
  • Academic/ Pathologist In-Charge of Histopathology Laboratory for the Division of Anatomical Pathology Department of Pathology
    01 Sep 2013 - 31 Dec 2022 (Department of Pathology, Faculty of Medicine)
  • Coordinator of Master of Pathology Part I- Conjoint
    01 Sep 2013 - 31 Dec 2022 (Department of Pathology, Faculty of Medicine)
  • Quality Manager
    01 Sep 2017 - 31 Dec 2022 (Department of Pathology, Faculty of Medicine)

MEMBERSHIPS

  • ACADEMY OF MEDICINE OF MALAYSIA, MEMBER
    Since 2014 (National)
  • COMMITTEE MEMBER, CHAPTER OF ANATOMICAL PATHOLOGY, COLLEGE OF PATHOLOGISTS, ACADEMY OF MEDICINE MALAYSIA, COMMITTEE MEMBER
    2021 to 2023 (National)
  • AP SPECIAL COMMITTEE COLLEGE OF PATHOLOGISTS, ACADEMY OF MEDICINE OF MALAYSIA (CPATHAMM), COMMITTEE
    2019 to 2020 (National)

AWARD AND STEWARDSHIP

  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2023 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2021 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2020 (University)

PUBLICATIONS

Article in Journal
WoS
  1. Hue, Susan Swee-Shan; Jin, Yu; Cheng, He; Bin Masroni, Muhammad Sufyan; Tang, Lloyd Wei Tat; Ho, Yong Howe; Ong, Diana Bee-Lan; Leong, Sai Mun; Tan, Soo Yong (2023). Tissue-Specific microRNA Expression Profiling to Derive Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas, CANCERS. 15(2). doi:10.3390/cancers15020453
  2. Ting, Choo-Yuen; Tan, Soo-Yong; Gan, Gin-Gin; Zain, Shamsul-Mohd; Pung, Yuh-Fen; Ong, Diana Bee-Lan; Bee, Ping-Chong (2022). Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 44(5), 907-917. doi:10.1111/ijlh.13928
  3. Zhai, Weiwei; Lai, Hannah; Kaya, Neslihan Arife; Chen, Jianbin; Yang, Hechuan; Lu, Bingxin; Lim, Jia Qi; Ma, Siming; Chew, Sin Chi; Chua, Khi Pin; Alvarez, Jacob Josiah Santiago; Chen, Pauline Jieqi; Chang, Mei Mei; Wu, Lingyan; Goh, Brian K. P.; Chung, Alexander Yaw-Fui; Chan, Chung Yip; Cheow, Peng Chung; Lee, Ser Yee; Kam, Juinn Huar; Kow, Alfred Wei-Chieh; Ganpathi, Iyer Shridhar; Chanwat, Rawisak; Thammasiri, Jidapa; Yoong, Boon Koon; Ong, Diana Bee-Lan; de Villa, Vanessa H.; Dela Cruz, Rouchelle D.; Loh, Tracy Jiezhen; Wan, Wei Keat; Zeng, Zeng; Skanderup, Anders Jacobsen; Pang, Yin Huei; Madhavan, Krishnakumar; Lim, Tony Kiat-Hon; Bonney, Glenn; Leow, Wei Qiang; Chew, Valerie; Dan, Yock Young; Tam, Wai Leong; Toh, Han Chong; Foo, Roger Sik-Yin; Chow, Pierce Kah-Hoe (2022). Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study, NATIONAL SCIENCE REVIEW. 9(3). doi:10.1093/nsr/nwab192
  4. Chai, C. S., Liam, C. K., Poh, M. E., Ong, D. B. L., Pang, Y. K., Cheah, P. L., . . . Alip, A. (2020). Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Cancer Management and Research, 12, 5439-5450. doi: 10.2147/cmar.s253760
  5. Chai, C. S., Liam, C. K., Poh, M. E., Ong, D. B. L., Pang, Y. K., Cheah, P. L., . . . Alip, A. (2020). Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Cancer Management and Research, 12, 5439-5450. doi: 10.2147/cmar.s253760
  6. Ting, C. Y., Gan, G. G., Ong, D. B. L., Tan, S. Y., & Bee, P. C. (2020). Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse. International Journal of Clinical Practice, 74(10), 10. doi: 10.1111/ijcp.13594
  7. Tan, J. S. J., Ong, K. C., Ong, D. B. L., Wu, Y. S., Razack, A., Kuppusamy, S., . . . Rhodes, A. (2019). Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer. Malaysian Journal of Pathology, 41(3), 243-251.
  8. Ting, C. Y., Liew, S. M., Price, A., Gan, G. G., Ong, D. B. L., Tan, S. Y., Bee, P. C. (2019). Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis. Critical Reviews in Oncology Hematology, 144, 11. doi: 10.1016/j.critrevonc.2019.102818
ESCI
  1. Khoo, Kah-Seng; Nadesalingam, Kavinya Diana T.; Ong, Diana Bee-Lan; Teoh, Li-Ying; Teh, Mei-Sze; Jamaris, Suniza; See, Mee-Hoong (2023). "An Unusual Pattern of Metastasis" Metastatic Malignant Thymoma Presented with Breast Lump: A Case Report and Literature Review, CASE REPORTS IN SURGERY. 2023. doi:10.1155/2023/3114843
Scopus
  1. Jeon A.-J., Anene-Nzelu C.G., Teo Y.-Y., Chong S.L., Sekar K., Wu L., Chew S.-C., Chen J., Kendarsari R.I., Lai H., Ling W.H., Kaya N.A., Lim J.Q., Chung A.Y.F., Cheow P.-C., Kam J.H., Madhavan K., Kow A., Ganpathi I.S., Lim T.K.H., Leow W.-Q., Loong S., Loh T.J., Wan W.K., Soon G.S.T., Pang Y.H., Yoong B.K., Bee-Lan Ong D., Lim J., de Villa V.H., dela Cruz R.D., Chanwat R., Thammasiri J., Bonney G.K., Goh B.K.P., Foo R.S.Y., Chow P.K.-H. (2023). A genomic enhancer signature associates with hepatocellular carcinoma prognosis, JHEP Reports. 5(6). doi:10.1016/j.jhepr.2023.100715
Others
  1. Weiwei Zhai, Hannah Lai, Neslihan Arife Kaya, Chen Jianbin, Hechuan Yang, Bingxin Lu, Jia Qi Lim, Siming Ma, Sin Chi Chew, Khi Pin Chua, Jacob Josiah Santiago Alvarez, Pauline Jieqi Chen, Mei Mei Chang, Lingyan Wu, Brian K P Goh, Alexander Yaw-Fui Chung, Chung Yip Chan, Peng Chung Cheow, Ser Yee Lee, Juinn Huar Kam, Alfred Wei-Chieh Kow, Shridhar Ganpathi Iyer, Rawisak Chanwat, Jidapa Thammasiri, Boon Koon Yoong, Diana Bee-Lan Ong, Vanessa H de Villa, Rouchelle D Dela Cruz, Tracy Jiezhen Loh, Wei Keat Wan, Zeng Zeng, Anders Jacobsen Skanderup, Yin Huei Pang, Krishnakumar Madhavan, Tony Kiat-Hon Lim, Glenn Bonney, Wei Qiang Leow, Valerie Chew, Yock Young Dan, Wai Leong Tam, Han Chong Toh, Roger Sik-Yin Foo, Pierce Kah-Hoe Chow Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in Hepatocellular Carcinoma: the PLANET study National Science Review, nwab192, https://doi.org/10.1093/nsr/nwab192
  2. Ting, C. Y., Gan, G. G., Bee-Lan Ong, D., Tan, S. Y., & Bee, P. C. (2020). Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse. International journal of clinical practice, 74(10), e13594. https://doi.org/10.1111/ijcp.1359
  3. CK Liam, CS Chai, ME Poh, DBL Ong, PL Cheah Acquired T790M Mutation in Patients Failing Treatment with First or Second Generation EGFR-Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology, 2019
  4. Clinical significance of aberrant microRNA expression in predicting disease relapse/ refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis
  5. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer
  6. DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma. Cheah PL, Li J, Looi LM, Teoh KH, Ong DB, Arends MJ. PeerJ. 2018 Sep 11;6:e5530. doi: 10.7717/peerj.5530. eCollection 2018.
  7. Phaik-Leng Cheah, Jing Li, Lai-Meng Looi, Kean-Hooi Teoh, Diana Bee-Lan Ong, Mark J. Arends. DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma. PeerJ 6(Suppl 1):e5530, September 2018.
  8. Tan JSJ, Ong KC, Ong DBL, Razack A, Lim J, Yunus R, Sundram M, Rhodes A.(2018). Heterogenous expression of ERG oncoprotein in Malaysian men with adenocarcinoma of the prostate. Malays J Pathol. 40(2): 103-110.
  9. Dass SD, Cheah PL, Ong DBL, Teoh KH, Looi LM. E-cadherin downregulation at the infiltrating tumour front is associated with histological grade and stage in colorectal carcinoma of Malaysians. Malays J Pathol 2015; 37(1):19-24
  10. Ngui R, Ravindran S, Ong DBL, Chow TK, Low KP, Nureena ZS, Rajoo Y, Chin YT, Amir A, Lim YAL, Mahmud R. Enterobius vermicularis salpingitis seen in the setting of ectopic pregnancy in a Malaysian patient. Journal of Clinical Microbiology 52(9):3468-3470

RESEARCH PROJECT

National
  1. 2023 - 2026, Fundamental Research Grant Scheme (FRGS)
    Elucidating The Molecular Mechanisms Of Exosomal Circltbp2-mediated Temozolomide Resistance In Glioblastoma Via C-met/stat3 Pathway And Mgmt Acetylation ( Co-Researcher)
  2. 2021 - 2026
    Interferon gamma in regulating Programmed Death-1 Ligand-1 (PD-L1): A prognostic marker in Malaysian non-small cell lung carcinoma (NSCLC), Taylor's University ( Co-Researcher)
  3. 2019 - 2025, Private Funding
    UM Breast Lymphoma Project. Biobanking, Registry and Biomarkers for multiracial population. Prospective cohort study. ( Consultant)
  4. 2019 - 2025
    UM Breast Lymphoma Project (Pink Lily) :Biobanking, Registry and Biomarkers for multiracial population. Prospective Cohort Study, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
  5. 2020 - 2024, Fundamental Research Grant Scheme (FRGS)
    Interferon gamma in regulating Programmed Death-1 Ligand-1 (PD-L1): A prognostic marker in Malaysian non-small cell lung carcinoma (NSCLC) ( Consultant)
  6. 2021 - 2023
    EOSINOPHILIC ESOPHAGITIS (EoE) IN A MALAYSIAN POPULATION - A SINGLE CENTRE ENDOSCOPY BASED STUDY, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
  7. 2021 - 2023
    The Silva Pattern Based Classification as Predictor of Lymph Node Metastasis in Endocervical Carcinoma. An Observational Pilot Study., University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
  8. 2018 - 2022
    PRACTICAL GENE MUTATION TESTING TO GUIDE TARGETED CANCER THERAPIES AND MICRORNA EXPRESSION FOR EARLY DETECTION OF DIFFUSE LARGE B CELL LYMPHOMA RELAPSE AND REFRACTORY, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
  9. 2017 - 2021, International Grant
    Practical gene mutation testing to guide targeted cancer therapies for relapsed and refractory Diffuse Large B cell Lymphoma Cancer (DLBCL) and a simple blood test for early detection of DLBCL cancer relapse ( Consultant)
Private
  1. 2021 - 2024, N/A
    MK 3475 587 A MULTICENTER, OPEN LABEL, PHASE III EXTENSION TRIAL TO STUDY THE LONG TERM SAFETY AND EFFICACY IN PARTICIPANTS WITH ADVANCED TUMORS WHO ARE CURRENTLY ON TREATMENT OR IN FOLLOW UP IN A PEMBROLIZUMAB TRIAL ( KEYNOTE 587 ) ( Co-Researcher)
  2. 2021 - 2024, N/A
    ML 41262 A PROSPECTIVE, MULTICENTER, NON INTERVENTIONAL GENOMIC PROFILLING STUDY IN SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) USING FOUNDATION MEDICINE ( Co-Researcher)
  3. 2021 - 2024, N/A
    INCMOR 0208-301 A PHASE 3, RANDOMIZED,DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TAFASITAMAB PLUS LENALIDOMIDE IN ADDITION TO RITUXIMAB VERSUS LENALIDOMIDE IN ADDITION TO RITUXUMAB IN PATIENT WITH RELAPSED / REFACTORY (R/R) FOLICULAR LYMPHOMA GRADE 1 TO 3A OR R/R MARGINAL ZONE LYMPHOMA ( Co-Researcher)
  4. 2021 - 2024, N/A
    MOR208C310 A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE VLIND, PLACEBO CONTROLLED TRIAL COMPARING THE EFFICACY AND SAFETY OF TAFASITAMAD PLUS LENALIDOMIDE IN ADDITION TO R CHOP VERSUS R-CHOP IN PREVIOUSLY UNTREATED, HIGH INTERMEDIATE AND HIGH RISK PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYPHOMA (DLBCL) / FRONTMIND ( Co-Researcher)
  5. 2021 - 2024, N/A
    LASER301 ( YH25448-301) A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAZERTINIB VERSUS GEFITINID AS THE FIRST LINE TREATMENT IN PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR SENSITIZING MUTATION POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER. SHORT TITLE: LAZERTINID VS GEFITINIB AS FIRST-LINE TREATMENT IN PATIENTS WITH EGFRm+ LOCALLLY ADVANCED OR METASTATIC NSCLC ( LASER301 ) ( Co-Researcher)
  6. 2021 - 2024, N/A
    EPIK-B3 (CBYL719H12301) A PHASE III, MULTICENTER, RANDOMIZED,DUOBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACYAND SAFETY OF ALPELISIB ( BYL719 ) IN COMBINATION WITH NAB-PACLITAXEL IN PATIENTS WITH ADVANCED TRIPLE NEGATIVE BREAST CANCER WITH EITHER PHOSPHOINOSITIDE-3-KINASE CAT-ALYTIC SUBUNIT ALPHA ( PIK3CA ) MUTATION OR PHOSPHATASE AND TENSIN HOMOLOG PROTEIN (PTEN) LOSS WITHOUT PIK3CA MUTATION ( Co-Researcher)
  7. 2021 - 2024, N/A
    MK 3475-671 A PHASE III, RANDOMIZED, DOUBLE-BLIND TRIAL OF PLATINUM DOUBLE CHEMOTHERAPY+/- PEMBROLIZUMAB (MK-3475) AS NEOADJUVANT/ADJUVANT THERAPY FOR PARTICIPANTS WITH RESECTABLE STAGE II,IIIA, AND RESECTABLE IIIB (T3-4N2) NON SMALL CELL LUNG CANCER (NSCLC) (KEYNOTE-671) ( Co-Researcher)
  8. 2021 - 2024, N/A
    CAPltello ( D3614C00001) A PHASE III, DOUBLE-BLIND RANDOMISED STUDY ASSESSING THE EFFICACY AND SAFETY OF CAPIVASERTIB + PACLITAXEL VERSUS PLACEBO + PACLITAXEL AS FIRST LINE TREATMENT FOR PATIENTS WITH HISTOLOGICALLY CONFIRMED, LOCALLY ADVANCED ( INOPERABLE ) OR METASTATIC TRIPLE NEGATIVE BREAST CANCER ( TNBC ) (CAPltello 290 ) ( Co-Researcher)
  9. 2022 - 2024, Stadpharm
    A PHASE IB/II SINGLE ARM, OPEN LABEL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CHIMERIC ANTIGEN RRECEPTOR (CAR)-T CELL THERAPY TARGETING THE CD19 ANTIGEN (AUXICART-19) FOR PATIENTS WITH RELAPSED OR REFRACTORY AGGRESSIVE B-CELL LYMPHOMA IN MALAYSIA, University of Malaya ( Co-Researcher)
International
  1. 2020 - 2025
    MicroRNA expression profiling for low grade lymphoma, National University of Singapore ( Co-Researcher)
  2. 2017 - 2022, International Funding
    A multi-national cohort study on the impact of intra-tumoural genomic heterogeneity and the immune micro-environment on the clinical trajectory of resected hepatocellular carcinoma. ( Consultant)
  3. 2018 - 2022, International Funding
    Study of miRNA profiling of low grade B-cell lymphoma cases. ( Consultant)
  4. 2018 - 2021, International Funding
    Sub-classification of DLBCL in GCB and non-GCB subtypes; sub-classify DLBCL using miRNA profiling and using Nanostring Lymph2Cx gene set as the gold standard. ( Consultant)

CONSULTANCY PROJECT

  • Consultant Pathologist for University Malaya Specialist Center, University Malaya Specialist Centre
    01 Dec 2017 - 01 Dec 2030 (National)

PAPER PRESENTED

INVITED SPEAKER
  1. The Role of Circulating DNA in Lymphoma, XVIIth MALAYSIAN NATIONAL SCIENTIFIC MEETING OF THE MALAYSIAN SOCIETY OF HAEMATOLOGY , Malaysian Society of Haematology (International) (10 Sep 2020 - 12 Sep 2020)
  2. Mantle Cell Lymphoma, 5th Malaysia Lymphoma Network Meeting, Malaysian Society of Hematology (National) (24 Sep 2016 - 24 Sep 2016)
  3. Molecular Pathology in Lung Cancer, Onco-Lead Workshop 2016, Malaysian Oncological Society (National) (20 Aug 2016 - 20 Aug 2016)
POSTER PRESENTER
  1. A RARE COLLISION TUMOUR OF PAPILLARY AND FOLLICULAR THYROID CARCINOMA, 54TH MALAYSIA - SINGAPORE CONGRESS OF MEDICINE IN CONJUNCTION WITH THE 47TH ANNUAL SCIENTIFIC CONGRESS OF THE COLLEGE OF SURGEONS , ACADEMY OF MEDICINE MALAYSIA, ACADEMY OF MEDICINE SINGAPORE, HONG KONG ACADEMY OF MEDICINE , COLLEGE OF SURGEONS ACADEMY OF MEDICINE OF MALAYSIA (International) (27 Aug 2021 - 29 Aug 2021)
  2. Early Disease Progression in Diffuse Large B-cell Lymphoma: Associated Clinical Features and Prediction Tool, XVIIth MALAYSIAN NATIONAL SCIENTIFIC MEETING OF THE MALAYSIAN SOCIETY OF HAEMATOLOGY, Malaysian Society of Haematology (International) (10 Sep 2020 - 12 Sep 2020)
  3. Title: Acquired T790M Mutation in Patients Failing Treatment with First- or- Second Generation EGFR-Tyrosine Kinase , IASLC 2019 World Conference on Lung Cancer, IASLC (International) (07 Oct 2019 - 10 Oct 2019)
  4. Title: Eosinophilic Liver Abscesses Mimicking Hepatic Malignancy, 6th IAPMD Annual Scientific Meeting 2019, IAP Malaysia (National) (07 Sep 2019 - 08 Sep 2019)
  5. Title: Practicality of MicroRNA Testing for Prediction of Disease Relapse/ Treatment Resistance and Good Response to Chemotherapy in Diffuse Large B-cell Lymphoma: A Systemic Review and MetaAnalysis., Department of Medicine Research Day, University of Malaya, Faculty of Medicine, University of Malaya (University) (10 Oct 2018 - 12 Oct 2018)
  6. Title: Predictors of Disease Progression in RCHOP treated- Diffuse Large B Cell Lymphoma, 15th MSH Annual Scientific Meeting, Navigating the World of Emerging Therapies, Malaysian Society of Hematology (National) (19 Apr 2018 - 21 Apr 2018)
OTHERS
  1. Resistance Mechanism Causing First-line Epidermal Growth Factor Receptor- TKI Treatment Failure, IASLC 18th World Conference On Lung Cancer October 15-18th 2017 Yokohama, Japan , IASLC (International) (15 Oct 2017 - 18 Oct 2017)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2024) Advisor/ Penasihat Kursus Program Diploma Teknologi Makmal, University, (Reviewer)
  2. (2021) Conjoint Universities Master of Pathology Examination, National, (External Examiner)
  3. (2021) Prevalence of Diffuse Large B-Cell Lymphoma Subgroup in University Malaya Medical Centre Based On Han Algorithm, University, (Internal Examiner)
  4. (2021) Immunohistochemistry Usage Profile in a Malaysia Tertiary Hospital Histopathology Laboratary, University, (Internal Examiner)
  5. (2020) Primary Extranodal Diffuse Large B-cell Lymphoma of The Uterine Cervix , (Reviewer)
  6. (2020) Appointed examiner for a research report. Dr Siti Sabrina Sohaimi MMJ 160003 MPath Final Year. Project: Correlation of Fine Needle Aspiration and Histopathological Examination in Thyroid Swelling in Hospital Pulau Pinang , (Internal Examiner)
  7. (2019) Academy of Medicine of Malaysia (CPathAMM) Anatomic Pathology Specialty Committee , (Advisory Committee)
  8. (2018) Appointed as a subcommittee for the proposal defense by PhD candidate, Idha Arfianti Wiraagni (MVA170014). Project: Monitoring of Substance Abuse and Selected Toxic Chemicals in Human Samples , (Advisory Committee)
  9. (2018) Appointed as committee member Jawatankuasa Penambahbaikan Kualiti PPUM , (Committee member)
  10. (2017) Reviewer for an article for The Malaysian Journal of Pathology. Article title: Unrecognized IgG4 association in progressively transformed germinal centers of lymph nodes with subsequent full-blown IgG4-related chronic fibrosing pancreatitis. December 2017 , (Reviewer)
  11. (2016) Systematic review of description of controls for immunohistochemistry stains using SOX10 for the diagnosis of malignant melanoma as an example., (Internal Examiner)
Contribution to external organisation
  1. (2024) Pelantikan Sebagai Penasihat Kursus Program Diploma Teknologi Makmal Perubatan, University, (Expert Advisor)
  2. (2024) Surat Ikatan Amanah Bagi Akaun Amanah, University, (Academic Appointment )
  3. (2024) Coordinator for Masters of Pathology Conjoint Universities Part 1, National, (Academic Appointment )
  4. (2024) Umsc Consultant Appointment, University, (Expert Advisor)
  5. (2023) Appointment as Committee Member, Chapter of Anatomical Pathology, College of Pathologists, Academy of Medicine Malaysia, National, (Academic Appointment )
  6. (2022) Senarai Bidang Kepakaran Yang Mengambil Behagian Di Dalam Peperiksaan Medex April 2021, National, (Expert Advisor)
  7. (2021) Appointment as Assessor for Division of Laboratory Medicine Internal Audit, University, (Auditor)
  8. (2021) Audit Pemantauan Ms Iso 9001 : 2015 Oleh Sirim Qas International Sdn Bhd Pada 2021, University, (Technical Advisor)
  9. (2021) Skim Akreditasi Makmal Malaysia Samm Audit 2021, National, (Technical Advisor)
Contribution to event
  1. (2023) Breast Carcinoma and Inflammatory Breast Diseases, International, (Panelist/Moderator)
  2. (2023) Updates in Lymphoma, National, (Panelist/Moderator)
  3. (2023) Lung Cancer Pathology, International, (Panelist/Moderator)
  4. (2021) Audit Dalaman Bahagian Patologi Anatomik, Jabatan Patologi, University, (Event Organiser)
  5. (2021) Conjoint University Masters of Pathology Intensive Course Main Organiser in Addition to Setting Exam Questions and Marking., National, (Event Organiser)
Mentoring
  1. (2022) Mentorship to Lim Xin Liang - Matrix No: Mia 170056, University, (Mentor)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2019) Expression of the oncogene ERG (v-ets erythroblastosis virus E26 oncogene homolog) and activation of the androgen receptor in prostate cancer, TAN JIA SHIN JESSICA
  2. (2018) Polymorphism in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG expression in Malaysian men with prostate cancer., Jessica Tan Jia Shin
Master
  1. (2020) -, NUR SYAZWANI JOHAL
  2. (2019) To be determined, Mohd Hazlin bin Jaffar
  3. (2019) The Silva Pattern-based Classification as predictor of lymph nodes metastases in endocervical adenocarcinoma: An observational pilot study from 2 institutions., Hanisah binti Jeffery
  4. (2019) -, CHEE WENG YAN SABRINA
  5. (2019) -, HANISAH BINTI JEFFREY
  6. (2019) -, MOHD HAZLIN BIN JAFFAR
  7. (2017) Diffuse Large B Cell Lymphoma, sub-classification, Venupriya A/P Ramasamy
  8. (2017) -, VENUPRIYA A/P RAMASAMY
  9. (2016) -, TAN KIM KWAN
Under Graduate Students
  1. (2021) LIM XIN LIANG MIA 170056

TEACHING

Master
  1. (2020) MKGA - Master of Pathology
  2. (2019) MKGA - Master of Pathology
  3. (2019) MKGA - Master of Pathology
  4. (2019) MKGA6101 - Paper 1 (McQ) Part 1
  5. (2018) MKGA - Master of Pathology
  6. (2017) MKGA6101 - Paper 1 (McQ) Part 1
  7. (2017) MKGA6103 - Paper 3 (Essay)
  8. (2017) MKGA6111 - Practical Part 1
  9. (2016) MKGA - Master of Pathology
  10. (2016) MKGA - Master of Pathology
  11. (2016) MKGA6101 - Paper 1 (McQ) Part 1
  12. (2016) MKGA6103 - Paper 3 (Essay)
  13. (2016) MKGA6111 - Practical Part 1
  14. (2015) MKGA6103 - Paper 3 (Essay)
  15. (2015) MKGA6111 - Practical Part 1
  16. (2014) MKGA - Master of Pathology
Bachelor
  1. (2020) MXEM - Histopathology (Senior) Phase Iiib- 7 December 2016
  2. (2020) UMMP - Ummp
  3. (2018) DDED2101 - Pathology
  4. (2018) MXEM - Histopathology (Senior) Phase Iiib- 7 December 2017
  5. (2018) UMMP - Ummp
  6. (2017) DDED2101 - Pathology
  7. (2017) MXEM - Histopathology (Senior) Phase Iiib- 7 December 2018
  8. (2017) UMMP - Ummp
  9. (2017) UMMP - Ummp

SOCIAL RESPONSIBILITY ACTIVITIES

  • A Volunteer Giving Online Tuition, Pot (Primary Online Tuition Sibkl) to Empower Families in Sabah Via Increasing Access to Quality Education for The Underserved Children in Sabah, (04 Jan 2021 - 07 Dec 2026) (National)
  • Peperiksaan Bersama Bahagian 1 Sarjana Patologi 2020 Organized, Conducted and Assessed The Conjoint Master of Pathology Part 1 Examination, (26 Oct 2020 - 05 Nov 2020)
  • Anatomical Pathology Department Ummc/ UM Internal Audit 2020 Organized and Conducted Ummc Laboratory Internal Audit, (29 Sep 2020 - 30 Sep 2020)
  • Master of Pathology Conjoint Entrance Exam 2020 Overall Academic Coordinator in The Preparation of Pathology Examination Questions (X100) for Medex 2020. Preparation and Proof Reading of The Entrance Examination Questions At Majlis Peperiksaan Malaysia., (15 Sep 2020 - 15 Sep 2020)
  • Xviith Malaysian National Scientific Meeting of The Malaysian Society of Haematology Speaker At The Scientific Meeting. Date: 10-12th September 2020 Venue: Shang-Ri La Hotel, Kuala Lumpur, Malaysia Title: The Role of Circulating Dna in Lymphoma, (10 Sep 2020 - 12 Sep 2020)
  • Organizing Committee for “Master of Pathology Curriculum Review Workshop”. Date: 29th -30th August 2019 Venue: Cube, Faculty of Medicine, UM, (29 Aug 2019 - 30 Aug 2019)
  • Organizing Committee for "Updates On Haematological Neoplasms" Faculty of Medicine, University of Malaya, (09 Dec 2017 - 09 Dec 2017)
  • Prostate Cancer Assessment Seminar/ Workshop, 17th November 2016, University of Malaya. Committee Member., (17 Nov 2016 - 17 Nov 2016)
  • 15th Annual Scientific Meeting 2016, Putrajaya Lakeside Hotel, Kuala Lumpur Being Part of The Organizing Committee in Making This National Conference a Successful One., (03 Jun 2016 - 05 Jun 2016)

COURSE ATTENDED

Internal / External Course
EXTERNAL COURSE
  1. NATIONAL RENAL PATHOLOGY WORKSHOP, Penang Medical College (21 Jul 2018 - 22 Jul 2018)
  2. CYTOPATHOLOGY UPDATE: LIQUID BASED CYTOLOGY AND HPV GENOTYPING & SCREENING MANAGEMENT, Advanced Surgical Skills Centre, UKM Medical Centre (29 Aug 2018 - 30 Aug 2018)
  3. EMERALD TEACHING AND LEARNING, Cube, Academy of Islamic Studies, University of Malaya (22 Oct 2018 - 26 Oct 2018)
  4. A TEACHER'S TOOLKIT: FOUNDATIONS OF ASSESSMENT FOR HEALTH PROFESSIONALS, Medical Education and Research Development Unit (Merdu) (03 Oct 2018 - 03 Oct 2018)
  5. A TEACHER'S TOOLKIT WORKSHOP ON FOUNDATIONS OF ASSESSMENT FOR HEALTH PROFESSIONALS, Faculty of Medicine, Bilik Serbaguna (24 Apr 2018 - 24 Apr 2018)
  6. UPDATES ON HAEMATOLOGICAL NEOPLASMS, Bilik Serbaguna, Faculty of Medicine, University Malaya (16 Nov 2019 - 16 Nov 2019)
  7. NATIONAL ONCOLOGY SUMMIT 2019, Intercontinental Hotel, Kuala Lumpur (06 Apr 2019 - 07 Apr 2019)
  8. 1.UNIVERSITY MALAYA HEPATOBILIARY PATHOLOGY WORKSHOP, Clinical Auditorium, Ummc (28 Feb 2019 - 01 Mar 2019)
  9. NATIONAL GENITOURINARY & FEMALE GENITAL TRACT PATHOLOGY, Hospital Pulau Pinang (27 Jul 2019 - 28 Jul 2019)
  10. ARE WE READY TO BRING IMMUNO-ONCOLOGY BIOMARKERS TO THE CLINIC?, Sheraton Imperial Hotel, Kuala Lumpur (29 Jun 2019 - 30 Jun 2019)
  11. MASTER OF PATHOLOGY CURRICULUM REVIEW WORKSHOP, Cube, Faculty of Medicine, University Malaya (29 Aug 2019 - 30 Aug 2019)
  12. THE 59TH IAP THAILAND ANNUAL MEETING 2019, Swissotel Bangkok, Ratchada, Thailand (06 Nov 2019 - 08 Nov 2019)
  13. UPDATES ON HAEMATOLOGICAL NEOPLASMS, Bilik Serbaguna, Faculty of Medicine (03 Nov 2018 - 03 Nov 2018)
  14. POST PROGRESSION TISSUE BIOPSY MASTERCLASS, New World Hotel Petaling Jaya & Subang Jaya Medical Centre, Malaysia (30 Jun 2018 - 30 Jun 2018)
  15. UPDATES ON HAEMATOLOGICAL NEOPLASMS, Bilik Serbaguna, Faculty of Medicine (09 Dec 2017 - 09 Dec 2017)
CONFERENCE
  1. CYTOPATHOLOGY SEMINAR: GYNAE, NON-GYNAE, HPV, UKM Medical Centre, Cheras (29 Aug 2018 - 30 Aug 2018)
  2. 59TH INTERNATIONAL ANATOMICAL PATHOLOGY THAILAND ANNUAL MEETING 2019, Swissotel Bangkok Ratchada (04 Nov 2019 - 10 Nov 2019)
  3. NATIONAL RENAL PATHOLOGY WORKSHOP 2018, Penang Medical College Malaysia (21 Jul 2018 - 22 Jul 2018)
  4. THE XVIITH MALAYSIAN NATIONAL SCIENTIFIC MEETING OF THE MALAYSIAN SOCIETY OF HAEMATOLOGY , Shangri- La Hotel, Kuala Lumpur (10 Sep 2020 - 12 Sep 2020)
INTERNAL COURSE- ORGANIZED BY PTJ
  1. WORKSHOP: EMERALD TEACHING & LEARNING, Universiti Malaya (22 Oct 2018 - 26 Oct 2018)
External Course
INTERNATIONAL
  1. AAPIAP Webinar - What's New in the GU WHO Webinar. Pathology ACP, Division of Pathology, Singapore General Hospital , Online (18 Sep 2021 - 18 Oct 2021)
  2. Paying Attention to Senior Health Care- Launching of Services, Online (23 Oct 2021 - 23 Oct 2021)
  3. Covid-19 and Breast Cancer. Setback or Reset? University Malaya- Breakfast@UMHealth, Online (06 Oct 2021 - 06 Oct 2021)
  4. Virtual Event: Advances in Molecular Testing- Lung Cancer Lifesciences solution- Thermo Fisher Scientific, Online (03 Apr 2021 - 03 Apr 2021)
  5. Hematolymphoid Pathology Workshop Prof Tan SY Department of Pathology, National University of Singapore Department of Pathology, University Malaya, Online (21 Dec 2021 - 21 Dec 2021)
  6. Hematolymphoid Pathology Workshop Prof Tan SY Department of Pathology, National University of Singapore Department of Pathology, University Malaya, Online (24 Nov 2021 - 24 Nov 2021)
  7. Hematolymphoid Pathology Workshop Prof Tan SY Department of Pathology, National University of Singapore Department of Pathology, University Malaya, Online (08 Dec 2021 - 08 Dec 2021)
  8. SG-ASEAN Pathology Webinar Series Liver SG-IAP, Online (11 Dec 2021 - 11 Dec 2021)
  9. Hematolymphoid Pathology Workshop Prof Tan SY Department of Pathology, National University of Singapore Department of Pathology, University Malaya, Online (09 Nov 2021 - 09 Nov 2021)
  10. 11th Annual Siriraj-Johns Hopkins Cytopathology Course Faculty of Medicine Siriraj Mahidol University Thailand, Online (29 Jul 2021 - 29 Jul 2021)
  11. SGIAP: Asean Pathology Webinar Series -Pulmonary, Online (26 Jun 2021 - 26 Jun 2021)
  12. Hematolymphoid Pathology Workshop Prof Tan SY Department of Pathology, National University of Singapore Department of Pathology, University Malaya, Online (27 Oct 2021 - 27 Oct 2021)
  13. Scientific Forum: Leading in Ovarian Treatment Advances (INNOVATE) AZ Scientific Exchange Multidisciplinary Forum, Online (10 Apr 2021 - 10 Apr 2021)
  14. SGIAP-ASEAN Pathology Webinar Series Gynaecology SG-IAP, Online (23 Oct 2021 - 23 Oct 2021)
  15. Precision Oncology and the Mismatch Repair Deficiency (dMMR) Mutational signature: Historical, Diagnostic and current Clinical Perspective MSD webcast, Webcast (26 Jan 2021 - 26 Jan 2021)
NATIONAL
  1. 2021 Lymphoma Network Meeting Ampang Hospital, Ministry Of Health., Online (17 Jul 2021 - 18 Jul 2021)
  2. Effectiveness and Safety of Covid-19 Vaccines in Older People Act4Health- University Malaya, Online (02 Jun 2021 - 02 Jun 2021)
  3. 1. My Research Journey in MBL 2. An in-vitro investigation of chemoresistance of bladder carcinoma University Malaya- Breakfast@UMHealth, Online (24 Nov 2021 - 24 Nov 2021)
  4. World AIDS Day 2021 Should Health Care Workers with HIV be Allowed to Work? University Malaya- Breakfast@UMHealth, Online (01 Dec 2021 - 01 Dec 2021)
  5. Topic: Is it a T cell lymphoma? IAPMD International Academy of Pathology Malaysian Division , Online (19 Dec 2021 - 19 Dec 2021)
  6. Basic Genomics & Introduction to Common Techniques in Molecular Pathology Title: Central dogma of molecular genetics, Online (20 Dec 2021 - 20 Dec 2021)
  7. Indoor Air and Covid-19 Detection, Online (28 Aug 2021 - 28 Aug 2021)
  8. 1.Covid-19 Vaccination in Pregnant Women 2. Fracture Liaison Services University Malaya- Breakfast@UMHealth, Online (03 Nov 2021 - 03 Nov 2021)
  9. Basic Genomics & Introduction to Common Techniques in Molecular Pathology Title: Genetic Variations, Online (30 Dec 2021 - 30 Dec 2021)